Annovis to Host Patients’ Live Forum on February 27, 2025

MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS)  ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), will host a live webcast where CEO Maria Maccecchini, Ph.D., will answer questions from patients, caregivers, and families about the Company’s clinical trials and future plans.

Original post:
Annovis to Host Patients’ Live Forum on February 27, 2025

Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference

Media ReleaseCOPENHAGEN, Denmark; February 19, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano and Chief Development Officer Judith Klimovsky will participate in a fireside chat at the 45th Annual TD Cowen Health Care Conference in Boston, Massachusetts at 1:50 PM EST (7:50 PM CET) on March 3, 2025.?A webcast of the fireside chat will be available on Genmab’s website at https://ir.genmab.com/events-presentations.

Read more:
Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference